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ABSTRACT 
Objective: To investigate the biochemical events that are associated with the skin softening, cleansing and wound healing properties of the 
cucumber (Cucumis sativus L) sap extract. 
Methods: Preparation of cucumber sap extract (CSE). Assay of CSE for proteolytic activity, plasma re-calcification time, APTT, PT, thrombin-like 
activity, plasmin-like activity, and effect on platelet aggregation and wound healing property by physical, biochemical and histological examinations. 
Appropriate positive and negative controls were maintained wherever necessary. 
Results: CSE decreased the plasma re-calcification time and prothrombin time (PT) and showed factor VII (pro-convertin) like activity. EGTA or 
EDTA pre-treated CSE did not alter the plasma recalcification time and PT. CSE readily hydrolyzed the plasma clot and azocasein; while, IAA pre-
treated CSE did not hydrolyze the plasma clot and azocasein. CSE inhibited the agonists collagen, ADP and epinephrine induced platelet aggregation 
in PRP in the order epinephrine>collagen>ADP with the respective IC50 of 22 ± 2.5, 20 ± 3 and 11 ± 2 µg/ml. PMSF pre-treated but not IAA and EDTA 
pre-treated CSE lost the platelet aggregation inhibition property. Further, CSE augmented wound healing process including the scar removal in a 
mouse model. The SOD, CAT, GSH activities and hydroxyproline, hexosamine and hexuronic acid contents were increased while, NO, LPO and MPO 
activities were decreased compared to control values. Histological study revealed accelerated wound healing involving epithelialisation and re-
formation of skin following CSE treatment compared to Neosporin. 
Conclusion: CSE contain metallo-, serine and cysteine proteases, and interfere in clot formation, dissolution and wound healing process, which 
validates the use of cucumber as cosmetics and to treat wounds by traditional healers.  
Keywords: Cucumber sap extract (CSE), Hemostasis, fibrin clot dissolution, Ethylene diamine tetra acetic acid (EDTA), Phenyl methyl sulphonyl 
fluoride (PMSF), Iodoacetic acid (IAA), Metalloprotease, Serine protease, Cysteine protease, Wound healing. 
 
INTRODUCTION 
Wounds are physical injuries that result in an opening or breaking of 
the tissue. The wound may be defined as a loss or breaking of 
cellular and anatomic or functional continuity of living tissues. 
Healing involves a complex biological process initiated in response 
to an injury that restores the function and integrity of damaged 
tissues. Clotting and removal of debris through inflammation, 
replacement of damaged tissue through proliferation of epithelial cells 
and maturation of scar are the essential events [1]. Untreated wounds 
are the potential place for the infection and chronic wounds may even 
lead to multiple organ failure. For example, management of diabetic 
wounds and eczema are still remained challenging and the lack of 
knowledge on the molecular mechanism of wound healing is the major 
limitation in identification of the precise target for the better 
management. Since time immemorial, herbal extracts are being tried 
extensively to achieve the better cure. Several plant species have been 
used in the Indian traditional systems of medicine such as Ayurveda, 
Siddha and Unani to treat wounds. Plants such as Azardica indica 
(Meliaceae), Lantana camara (Verbenaceae), Tridax procumbens 
(Asteraceae), Hydnocarpus wightianus (Achariaceae), Ginkgo biloba 
(Ginkgoaceae) and Centella asiatica (Apiaceae) with promising wound 
healing efficacy have been evaluated scientifically [2]. 
Cucumber from Cucumis sativus. L (Cucurbitaceae) commonly 
known as melon or gourd or cucurbit has been extensively used for 
external applications to treat various skin disorders such as 
wrinkles, chink, skin mold, freckles, sunburn, hyper-pigmentation, 
burning sensation, acne, dark circles, skin rashes, burns, wounds and 
bedsores. It is also used to treat tuberculosis, fever, insomnia, 
headache, jaundice, haemorrhage, kidney diseases, calculi, 
dyspepsia, diabetes, gout, obesity, arthritis, bronchitis, stomach 
pains, rheumatic problems, constipation, tonsillitis, cancer, 
inflammation and heart problems [3-5]. Thus, from ancient to 
modern world, the cucumber is being used extensively as an 
external applicant in the cosmetic industry and as well as to treat 
wounds, but without having any scientific validation. Therefore in 
the present study cucumber sap extract in tissue remodelling and 
wound healing process have been studied in a mouse model and the 
results are presented. 
MATERIALS AND METHODS 
Cucumbers (Cucumis sativus L.) were purchased from Krishna Raja 
Market in month March 2013 and authenticated by 
expertise/botanist, Botany department, University of Mysore 
Mysore, India (voucher specimen facility is not available). Thrombin, 
urokinase, ADP, collagen type I and epinephrine were purchased 
from Sigma Chemicals Company (St. Louis, USA). UNIPLASTIN, 
LIQUICELIN-E and factor-X and VII deficient plasma were purchased 
from Tulip Diagnostics Pvt. Limited. Blood was collected from 
healthy donors (Sanction order-IHEC-UOM No.71). Adult Swiss 
Albino mice (30-35 g; either gender) were obtained from the Central 
Animal House Facility, DOS in Zoology, University of Mysore 
(Sanction order-UOM/IAEC/6/2012). The animal care and 
experimental procedures performed were in compliance with the 
Regulations for Animal Research and Animal Ethical Committee of 
the UOM. Ketamine and xylocaine were purchased from the 
University Medical facility with a prescription from the University 
authorized medical practitioner. Ethylene diamine tetra acetic acid 
(EDTA), phenyl methyl sulphonyl fluoride (PMSF), and iodoacetic 
acid (IAA), was purchased from Sigma Chemicals Company (St. 
Louis, USA) and PDMAB (para-dimethyl amino benzaldehyde) from 
Sisco Research Laboratory (Mumbai, India). Gelatin and antibiotic 
Neosporin skin ointment (Neomycine+polymyxin B 
sulphate+bacitracin zinc) were obtained from Qualigens Fine 
Chemicals and GlaxoSmithKline Pharmaceuticals (Mumbai, India). 
All other chemicals used in this study were of analytical grade.  
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Preparation of cucumber sap 
The outer green layer of cucumber was peeled and crushed in saline 
(0.9%), stirred overnight using magnetic stirrer. The extract was 
centrifuged for 10 min at 8000 rpm, the supernatant was collected and 
the pellet was discarded. Chilled acetone was added to the supernatant 
in the ratio 2:1 and kept overnight at 4oC and centrifuged for 10 min at 
8000 rpm. The pellet was collected and the supernatant was 
discarded. The pellet was dissolved in minimum distilled water and 
dialyzed using dialysing bag (10 KDa cut off) in double distilled water. 
The dialyzed sample was centrifuged for 10 min at 8000 rpm and the 
supernatant was collected and designated as cucumber sap extract 
(CSE) and stored at-20 oC for further use [6]. 
Plasma re-calcification time 
The plasma re-calcification time was determined according to the 
method of Quick [7]. Briefly, the CSE (2.5 to 100 µg) was pre-
incubated with 0.2 ml of citrated human plasma in presence of 10 
mM Tris-HCl (20 µl) buffer pH 7.4 for 5 min at 37oC. For the 
inhibition of proteolytic activity, the CSE (25 µg) was pre-incubated 
independently with known protease inhibitors such as EDTA, PMSF 
and IAA (10 mM) for 30 min at 37 oC and then 20 µl of 0.25 M CaCl2 
was added to the pre-incubated mixture and clotting time was 
recorded in seconds. 
Activated partial thromboplastin time (APTT) and prothrombin 
time (PT) 
Briefly, 100 µl of normal citrated human plasma was pre incubated for 
1 min with CSE (2.5 to 100 µg). For APTT, 100 µl reagent 
(LIQUICELIN–E Phospholipids preparation derived from rabbit brain 
with ellagic acid) which was activated for 3 min at 37 °C was added 
and the clotting was initiated by adding 100 µl 0.25 M CaCl2. For PT 
activity, the clotting was initiated directly by adding 200 µl PT reagent 
(UNIPLASTIN/lIQUIPLASTIN-rabbit brain thromboplastin). In both 
the cases, the clotting time was recorded in seconds by observing the 
formation of visible clot against a light source. Plasma sample treated 
with no CSE served as controls in both the cases. CSE (25 µg) was 
preincubated independently for 30 min with 10 mM each of EDTA, 
PMSF and IAA at 37 oC for inhibition of proteolytic activity, 
Thrombin-like activity 
Thrombin-like activity was determined according to the method of 
Denson [8]. The assay volume of 0.4 ml with 0.5% human fibrinogen 
in the presence of 10 mM Tris-HCl (40 µl) buffer pH 7.4 was treated 
with the CSE (2.5 to 100 µg) and the mixture was agitated gently 
against a light source to record the formation of the visible clot in 
seconds at room temperature. For control experiments, fibrinogen 
was treated with the thrombin. The clotting time was then 
determined after the addition of 100 μl of thrombin (2.5 NIH 
units/ml) to 100 μl of the incubation sample. For inhibition of 
proteolytic activity, CSE (100 µg) was preincubated independently 
for 30 min with 10 mM each of EDTA, EGTA, PMSF and IAA at 37 oC. 
Factor VIIa-like activity 
Factor VIIa-like activity was assayed using the congenital factor VII 
deficient human plasma. The different concentration of CSE (2.5 to 
100 µg) was incubated with 100 µl of congenital factor VII deficient 
plasma for 2 min at 37 °C. The clotting time was recorded in seconds 
after adding 30 µl of 0.25 M CaCl2 against a light source. Normal 
plasma, 200 µl treated with 30 µl 0.25 M CaCl2 served as control 
experiments. For inhibition of proteolytic activity, CSE (100 µg) was 
pre incubated independently for 30 min with 10 mM each of EDTA, 
PMSF and IAA at 37 oC. 
Fibrinolytic activity 
The citrated human plasma (100 µl) was mixed with 30 µl of 0.25 M 
CaCl2 and kept at 37 oC for 3 h to form the soft fibrin clot. The clot 
was washed thoroughly for 5-6 times with phosphate buffered saline 
(PBS), suspended and incubated with the CSE (5 to 150 µg) 
independently in a final volume of 500 µl of 0.2 M Tris-HCl buffer pH 
8.5 for 2 h at 37 oC. The undigested clot was precipitated by adding 
750 µl of 0.44 M of TCA and allowed to stand for 30 min at room 
temperature; it was then centrifuged for 15 min at 1500xg. About 
0.5 ml of the supernatant was transferred to a clean glass tube 
followed by the addition of 1.25 ml of 0.44 M Na2CO3, 0.25 ml of 1:3 
diluted Folin ciocalteus reagent and the colour developed was read 
at 660 nm. For inhibition of proteolytic activity, CSE (100 µg) was 
pre incubated independently for 30 min with 10 mM each of EDTA, 
PMSF and IAA at 37 oC. The semi-quantitative assay was also done 
using the plate method. Fresh human blood was mixed with 
anticoagulant (0.11 M trisodium citrate, 0.2% EDTA) in the ratio 9:1 
and centrifuged for 15 min at 500g to separate platelet poor plasma. 
A mixture consisting of 2 ml of platelet poor plasma, 3 ml of 1.2% 
agarose in 10 mM Tris–HCl, 0.15 M NaCl, 0.05% sodium azide and 
0.25 M CaCl2 was poured into 10 mm x 99 cm flat Petri dish and left 
for 2 h at 25 oC. CSE (25 to 100 µg) in 10 mM Tris-HCl buffer (pH 
7.4), protease inhibitors such as EDTA, 1,10-Phenanthroline, PMSF, 
Benzydamine hydrochloride and IAA (10 mM) were pre-incubated 
independently with CSE (25 µg) for 30 min at 37 oC and placed on 
the surface and incubated overnight at room temperature. Then 
0.01% TCA was added over the surface and the diameter of the trans 
lucent clear zones due to lyses of the fibrin clot (plaque) were 
measured in millimetre (mm). Urokinase, 2.5 units served as control. 
Plasminogen activation assay 
The plasminogen activation assay was done according to the method 
described by Chakrabarty et al., [9]. (a) Human citrated plasma (20 
µl), (b) Human citrated plasma (20 µl) with 1 mg (10 µl) urokinase, 
(c) Human citrated plasma (20 µl) with 50 µg CSE, (d) 50 µg CSE 
alone and (e) 1 mg urokinase alone were independently incubated 
for 1 h at 37 °C in 100 µl of 100 mM potassium phosphate buffer and 
the reaction was initiated by adding 500 µl of azocasein (0.25% in 
100 mM potassium phosphate buffer pH 7.4). Addition of 400 µl of 
25% trichloroacetic acid abolished the activity and it was 
centrifuged at 1000xg for 15 min. The supernatant (600 µl) was 
diluted with an equal volume of 0.5 N NaOH and absorbance was 
read at 440 nm. For inhibition of proteolytic activity, CSE (50 µg) 
was pre incubated independently for 30 min with 10 mM each of 
EDTA, PMSF and IAA at 37 oC. 
Preparation of platelet-rich plasma and platelet-poor plasma 
The freshly collected blood from healthy donors, who were non-
smokers and non-medicated at least for the previous 15 days, was 
mixed with 0.11 M trisodium citrate (9:1 ratio) and centrifuged at 
90xg for 15 min to obtain platelet-rich plasma (PRP). The remaining 
blood was again centrifuged at 500 xg for 15 min to obtain the 
platelet poor plasma (PPP). The platelet number in the PRP was 
adjusted to 3.8×108 platelets/ml by diluting with PPP and used 
within 2 h. All the above preparations were carried out using plastic 
wares or siliconized glass wares. 
Platelet aggregation 
The turbidometric method of Born [10] was followed using a 
Chronolog dual channel aggregometer connected to an omniscribe 
dual pen recorder to record the light transmission as a function of 
time. The reaction volume 500 µl contain 0.45 ml PRP was pre-
incubated with CSE (5 to 50 µg) for 3 min in a cylindrical glass 
cuvette under constant stirring. The aggregation was initiated by the 
addition of agonists such as collagen (2 μg/ml), ADP (5 mM) and 
epinephrine (5 mM) respectively and the aggregation was followed 
for 6 min. Further, CSE was also checked for its effect on platelet 
aggregation in the absence of any agonists. As platelets aggregate, 
light transmission increases progressively producing an aggregation 
trace on the recorder. The aggregation trace was the plot of light 
transmission between platelet rich plasma (PRP) and platelet poor 
plasma (PPP) base line, which represent 0% and 100% aggregation 
respectively. For inhibition of proteolytic activity, CSE (50 µg) was 
pre incubated independently for 30 min with 10 mM each of EDTA, 
PMSF and IAA at 37 oC. 
Wound healing activity 
The wound healing activity of CSE was determined using the 
excision wound model [11]. About 10 cm diameter area was shaved 
and sterilized with 70% alcohol on the dorsal side of the mouse. 
Further, a full thickness excision wound of 1 cm diameter was made 
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using sharp scissor and samples were applied over the entire wound 
twice a day up to 21 days starting from day of wounding. Four 
groups (n = 3) of mice were used for the study. Group Ia-Id: wounds 
were treated with saline (negative control), Group IIa-IId: wounds 
were treated with CSE (10 mg/kg body wt), Group IIIa-IIId: wounds 
were treated with heat denatured CSE and Group IVa-IVd: wounds 
were treated with Neosporin (positive control) respectively for 3, 7, 
14 and 21 days. Wound contraction (diameter of the wound 
calculated by tracing margins of the wound on a graph sheet) was 
monitored daily and the percentage of wound closure was calculated 
using the formula, % wound contraction = [Healed area/Total wound 
area] × 100 (Healed area= original wound area − present wound 
area). Mice were anesthetized by intraperitoneal injection of 
ketamine-xylocaine mixture [12] on the respective days. The healing 
skin from each group was taken and fixed in Bouin’s solution for a 
period of three days for histopathology. 
Histopathology studies 
Skin samples were stored in Bouin`s solution was subjected to 
dehydration process through different grades of alcohol and 
chloroform mixture. Finally, the samples were placed in chloroform. 
The tissues were embedded in molten paraffin wax and 5 μm thick 
sections were prepared using Spencer 800 microtome. The sections 
were stained with hematoxylin-eosin stain for microscopic 
observations according to the standard procedure. The sections 
were observed under Leitz wetzlar Germany type (307-148.002) 
microscope and photographed using Photomet-rics colorsnap CF 
camera (Leitz Diaplan Germany, Roper Scientific Photometrics type-
A014872002) attached to the microscope. 
Estimation of antioxidants and free radicals in granulation tissue 
Wet granulation tissues of mice from each group were homogenized 
in a glass teflon homogenizer (10% w/v) at 4 °C in phosphate 
buffered saline (PBS, pH 7.2) and used for the assays. Antioxidant 
markers such as superoxide dismutase (SOD) [13], catalase (CAT) 
[14] and reduced glutathione (GSH) [15] were estimated. Free 
radical markers such as nitric oxide (NO) [16], lipid peroxidation 
(LPO) [17], acute inflammatory marker myeloperoxidase (MPO) [18] 
were estimated. In addition the protein content [19] was also 
estimated. The assay of SOD is based on the inhibition of the 
formation of NADH-phenazine methosulphate-nitro blue tetrazolium 
formazan. One unit of enzyme activity was defined as the amount of 
enzyme that gave 50% inhibition of nitro blue tetrazolium reduction 
in one minute. CAT measurement was done based on the ability to 
oxidize hydrogen peroxide to water and molecular oxygen. One unit 
of enzyme activity was defined as the enzyme which decomposes 
one mM of H2O2/min at 25 °C. GSH activity was estimated by the 
ability of GSH to reduce DTNB (5, 5’-dithiobis nitro benzoic acid) to 
2-nitro-5-thiobenzoate (TNB) within 5 min against blank and the 
amount of reduced GSH was expressed as nanomoles of GSH/mg. 
LPO levels were estimated in terms of malondialdehyde (MDA) 
released during lipid peroxidation and expressed in nanomoles of 
MDA/mg. Nitrites and nitrates formed during NO formation were 
measured by using Griess reagent and expressed as units/mg. For 
myeloperoxidase (MPO) estimation, granulation tissue (5% w/v) 
was homogenized in 0.5% hexa decyl trimethyl ammonium bromide 
(HTAB, Sigma-Aldrich, Co., St. Louis, MO, USA) with 50 mM 
potassium phosphate buffer (pH 6). The previous homogenate was 
freeze-thawed three times, sonicated for 10 seconds and then 
centrifuged at 14000×g for 45 minutes at 4 °C and the resulting 
supernatant was used for estimation of MPO. One unit of MPO 
activity was defined as that converting 1 mol of H2O2 to water in 1 
min at 25 °C.  
Estimation of connective tissue parameters 
The wet granulation tissue samples from each group were dried at 50 
°C for 24 h and 40 mg was weighed from each group and transferred 
to clean and dry test tubes and suspended in 1 ml of 6 N HCl and boiled 
in the water bath for 24 h. The hydrolysate was then cooled and excess 
of acid was neutralized by adding 10 N NaOH using phenolphthalein as 
an indicator. The volume of neutral hydrolysate was diluted to a 
concentration of 20 mg/ml with distilled water and used for the 
estimation of hydroxyproline [20], hexosamine [21] and hexuronic 
acid [22]. The respective standards such as 4-Hydroxy-L-proline (75 to 
900μg/0.3 ml), D (+) glucosamine hydrochloride (5 to 50μg/0.5 ml) 
and D (+) Glucurono-6, 3-lactone (5 to 40 μg/0.5 ml) were used to 
prepare standard curves.  
Protein estimation 
Protein content was determined by Biuret method [23].  
Statistical analysis 
The experiments were repeated for three independent observations. 
Results were expressed as mean±SEM values. Data were compared 
by analysis of variance (ANOVA) followed by Bonferroni post hoc 
test for multiple compari-sons; significance was accepted at P<0.05 
(*), P<0.01 (**), and P<0.001 (***). Data were analyzed using the 
statistical package GraphPad Prism (GraphPad Soft-ware, Inc., USA). 
RESULTS 
Initial screening for the proteolytic activity revealed that the 
cucumber pulp showed insignificant activity while the activity was 
significant in the green skin peel and thus the cucumber sap was 
prepared from the later. The crude saline extract of cucumber sap 
was subjected to chilled acetone precipitation in the ratio 1: 2 
(extract: acetone). The precipitate was re-suspended and dialyzed in 
distilled water and centrifuged, the supernatant was called (CSE) 
and used for further studies as a source of protease activity. CSE 
showed proteolytic activity on casein with the specific activity of 
2.27±0.6 units/mg/min [6].  
CSE showed procoagulant activity as it reduced the re-calcification 
time of citrated human plasma from 266±3.5 sec to 141±0.7 sec (fig. 
1A) and the effect was found to be dose dependent. EDTA and EGTA 
abolished, while PMSF and IAA did not affect the plasma 
recalcification time of CSE (table 1). CSE also reduced the 
prothrombin time (PT) of citrated human plasma dose dependently 
from 16±2 sec to 5±2 sec (fig. 1B). Further, preincubation of CSE 
with EDTA abolished the PT activity while it was insensitive to PMSF 
and IAA pre-treatment (table 1). CSE also showed the thrombin time 
(TT) dose dependently, but the effect observed was very feeble as 
compared to the control where thrombin showed the clotting time of 
26±2 sec. Further, the thrombin time was also abolished by EDTA 
while PMSF and IAA did not affect (data not shown). 
 
 
Fig. 1: Effect of CSE on plasma recalcification time, Prothrombin time and congenital factor VII deficient human plasma  
(A) Dose dependent effect of CSE (5-100 µg) on human citrated plasma. (B) Dose dependent effect of CSE (5-100 µg) on citrate human 
plasma with prothrombin time reagent. (C) Dose dependent effect of CSE (5-100 µg) on congenital factor VII deficient human plasma and 
the assay was carried out as explained in ‘materials and methods’ section. Results are presented as the mean±SEM 
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When tested on the factor VII deficient congenital human plasma, 
CSE induced the clotting in a dose dependent manner, and at 100 µg, 
the clotting time observed was 254±13 sec (fig. 1C), and this effect 
was abolished by EDTA but not by PMSF and IAA (table 1). The 
factor VII deficient plasma was insensitive to the added CaCl2, while 
the normal citrated human plasma showed the recalcification time of 
267±4 sec which served as control.  
 
Table 1: Effect of protease inhibitors on recalcification time, 
prothrombin time and factor VII eficient plasma clotting 
property of CSE 
Samples Clotting time 
Recalcification time (Sec) 
Control (Normal plasma) 262±04 
CSE (25µg) 182±07 a*** 
CSE (25µg)+PMSF (10 mM) 179±14 
CSE (25µg)+IAA (10 mM) 180±13 
CSE (25µg)+EDTA (10 mM) No clot formation b*** 
CSE (25µg)+EGTA (10 mM) No clot formation b*** 
Prothrombin time (Sec) 
Control (Normal plasma) 16±2 
CSE (25µg) 13±2 a*** 
CSE (25µg)+PMSF (10 mM) 12±2 
CSE (25µg)+IAA (10 mM) 13±3 
CSE (25µg)+EDTA (10 mM) No clot formation b*** 
CSE (25µg)+EGTA (10 mM) No clot formation b*** 
Factor VII deficient plasma clotting time (Sec) 
Control (Normal plasma) 262±04 
CSE (50µg) 382±20 a*** 
CSE (50µg)+PMSF (10 mM) 379±21 
CSE (50µg)+IAA (10 mM) 381±23 
CSE (50µg)+EDTA (10 mM) No clot formation b*** 
CSE (50µg)+EGTA (10 mM) No clot formation b*** 
 
Results are presented as the mean±SEM and analyzed using one-way 
ANOVA followed by ‘Bonferroni's multiple comparison test 
(***P<0.0001, a significant when compared to clotting time of 
control, b significant when compared to CSE treated samples). 
CSE hydrolysed the washed fibrin clot dose dependently with the 
specific activity of 0.475±0.026 units/mg/min. PMSF and IAA 
inhibited the clot hydrolysing activity and the inhibition achieved 
was (95±2%) and (11±4%) respectively while, EDTA didn’t inhibit 
(fig. 2A and 2B). The degradation of fibrin was further confirmed 
by the semi-quantitative fibrinolytic assay on agarose plate 
method in which the CSE (100 µg) revealed the clear zone of fibrin 
hydrolysis of 7.5±0.04 mm diameter. PMSF, benzidine 
hydrochloride and IAA inhibited, while EDTA and EGTA did not 
inhibit the fibrinolytic activity of CSE (fig. 2C and 2D). Urokinase 
(2.5 units) revealed the zone of hydrolysis of 12±0.02 mm which 
served as positive control. In plasminogen activation assay, the 
urokinase didn’t hydrolyze azocasein while CSE hydrolyzed the 
azocasein dose dependently when incubated independently. The 
azocasein hydrolysing activity of CSE was inhibited to the extent of 
86% by IAA and 12% by PMSF while EDTA did not inhibit (data 
not shown). 
CSE inhibited the epinephrine, collagen and ADP induced platelet 
aggregation dose dependently and the order of inhibition was found 
to be epinephrine>collagen>ADP with the respective IC50 values of 
22±2.5, 20±3, and 11±2 µg/ml (fig. 3A, B and C). The platelet 
aggregation property of CSE was abolished by PMSF while it was 
insensitive to EDTA and IAA (fig. 3D, E and F). 
CSE was tested for wound healing property and it was followed 
from day 3rd to 21st days. CSE readily promoted wound healing in 
a Swiss albino mouse model. The rate of wound contraction 
achieved in CSE, positive control (PC), negative control (NC), and 
B-CSE (boiled CSE) treated wounds were found to be 25 to 99%, 
27 to 96%, 16 to 75%, 17 to 78% respectively (fig. 4 A and B). In 
case of CSE treated wound, complete scar free healing was 
observed on 21st day of treatment and this was highly comparable 
to the healing rate of Neosporin treated control (PC) wound, while 
the healing was achieved at 25th day of treatment in case of NC 
and BSE treated wounds. 
  
 
Fig. 2: Effect of CSE on fibrin clot hydrolysis and inhibition by protease inhibitors. A represents the effect of CSE on fibrin clot hydrolysis. B 
represents the effect of protease inhibitors on CSE towards hydrolysis of fibrin clot. Protease inhibitors (10 mM) were preincubated 
independently with CSE (100 µg) for 30 min at 37 °C. C represents the effect of CSE on fibrin clot hydrolysis by plate method. 1 (2.5 units 
urokinase), 2, 3, 4 (25, 50, and 100 µg CSE respectively). D represents the effect of protease inhibitors on fibrinolytic activity of CSE. 1 (2.5 
units urokinase), 2 (CSE 25 µg), 3 (CSE 25 µg+EDTA), 4 (CSE 25 µg+PMSF), 5 (CSE 25 µg+benzydamine hydrochloride), 6 (CSE 25 µg+EGTA) 
and 7 (CSE 25 µg+IAA) respectively and the assay was carried out as explained in the Methods section. Results are presented as the 
mean±SEM (***P<0.0001, significant when compared to CSE.) 
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Fig. 3: Effect of CSE and protease inhibitors on platelet aggregation of human platelet rich plasma: A, B and C represents the dose dependent 
effect of CSE (5-50 µg) on platelet aggregation induced by epinephrine, collagen and ADP respectively. D, E and F represents the effect of 
EDTA, PMSF and IAA (10 mM) on platelet aggregation activity of CSE (50 µg) induced by ADP, collagen and epinephrine respectively. For 
inhibition studies the protease inhibitors were pre-incubated independently with CSE for 30 min at 37 °C and platelet aggregation was 
performed as described in the methods section. Results are presented as the mean±SEM and analyzed using one-way ANOVA followed by 
Bonferroni's multiple comparison Test (***P<0.0001, significant when compared to aggregation induced by epinephrine, collagen and ADP) 
 
 
Fig. 4: Effect of CSE on wound healing activity using mouse model: 
10 mm diameter full thickness excision wounds were surgically 
made on the dorsal portion of mice. An amount of 250 µg of CSE was 
applied twice daily on the wound (10 mg/kg/day). A represents the 
photographic representation of percentage of wound contraction 
from day 3 to 21 of cucumber sap extract (CSE) Neosporin, negative 
control (NC), and boiled extract of CSE (B-CSE). B represents the 
wound contraction which was monitored by measuring the 
diameter of the wound using a graph sheet. Results are expressed 
as a percentage of wound closure and are presented as the 
mean±SEM and analyzed using two-way ANOVA followed by 
Bonferroni's multiple comparison Test (*** P<0.0001, signi ficant 
when compared to negative control (NC) group of mice) 
 
On respective days, such as 3rd, 7th, 14th, and 21st days of treatment, 
the animals from all the groups were sacrificed to remove skin tissue 
at the site of wound healing and subjected for histopathology. The 
CSE and Neosporin treated wound tissue sections revealed the 
accumulation of large number of inflammatory cells at 3rd day, as 
compared to NC and B-CSE.  
 
 
Fig. 5: Histopathology of skin granulation tissue of mice from day 
3 to 21 stained with Hematoxylin-Eosin. Tropical application of 
CSE (250 µg), standard cream Neosporin and boiled CSE extract 
twice a day for wounded skin of albino mice till 21 days. After 3, 7, 
14 and 21 days the mice were scarified in each group. The skin 
was dissected and processed for hematoxylin-eosin staining. 
Images were under microscope and photographed (10X). [Note: 
Cucumber sap extracts (CSE), Neosporin, Negative control (NC), 
Boiled extract of CSE (B-CSE) M-Macrophages, IC-inflammatory 
cells, C-collagen, BV-blood vessel, CB-collagen bundles, FB-
fibroblast, DC-dense collagen and EC-intact extracellular matrix] 
 
At 7th day, there observed an increased formation and accumulation 
of collagen bundles in CSE and Neosporin treated tissue sections as 
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compared to NC and B-CSE. On day 14, an increased collagen 
network and less numbers of inflammatory cells with a relatively 
intact extracellular matrix in CSE and Neosporin treated sections 
were prominently noticed while contrasting features were 
associated with NC and B-CSE treated wound tissue sections. On day 
21st, the normal collagen, intact extracellular matrix and with no 
significant inflammatory cells characteristic of normal tissue has 
been restored in CSE and Neosporin treated wound tissue sections. 
However, the normal histological features did not restore even after 
day 25th in NC and B-CSE treated wound tissue sections (fig. 5). 
 
Fig. 6: Estimation of biochemical parameters of granulation 
tissue. A, B, and C represents the content of hydroxyproline, 
hexosamine and hexuronic acid of 3 to 21 days granulation 
tissue of mice treated with CSE (cucumber sap extract), 
Neosporin, NC (negative control, without any treatment) and B-
CSE (boiled extract of CSE). Respective assay was performed as 
described in the Methods section. Results are presented as the 
mean±SEM and then analyzed using two-way ANOVA followed 
by Bonferroni post-tests (*** P<0.001, significant when 
compared to the negative control group of mice) 
 
Further, the tissues at the site of wound from each group of mice 
were studied for antioxidant markers, free radical scavenging 
activity and biochemical parameters. The antioxidant markers such 
as SOD and CAT activities, and GSH levels were increased 
significantly from day 3rd to 14th day, however their levels decreased 
drastically in CSE and Neosporin treated wound tissues at 21st day, 
as compared to NC and B-CSE (table 2). Free radicals such as NO and 
LPOs levels, and acute inflammatory marker MPO activity were 
decreased gradually from day 3rd to 21st day in CSE and Neosporin 
treated wound tissues, while their levels remained high in NC and B-
CSE treated wound tissues (table 2). The biochemical parameters 
such as hydroxyproline, hexosamine and hexuronic acid contents 
were significantly increased from day 3rd to 21st day of CSE and 
Neosporin treated tissue sections as compared to NC and B-CSE 
which showed marked decreased levels (fig. 6A, B and C). 
DISCUSSION 
The wound is generally characterized by the damage of tissues and 
vascular endothelium resulting in the onset of complex acute 
phase events such as primary and secondary hemostasis and 
inflammatory response which not only offer protection to the 
wound but also prevent spreading of wound due to the possible 
infection. However, removal of the fibrin clot and debris, and 
replacement of damaged tissue through the proliferation of 
epithelial cells and maturation of scar are the essential events of 
wound healing. It is a highly complex and tightly regulated process 
involving the symphony of variety of factors such as platelets, 
collagen, blood clotting factors, cytokines, chemokines, hormones, 
proteases etc. At the time of wound formation, the clotting of blood 
is critical to prevent the fatal haemorrhage while the dissolution of 
clot is equally essential during wound healing. Proteases, which 
are the key factors known to participate in both of these processes. 
The results of this study systematically evaluated the beneficial 
effects of the CSE where the proteolytic activity play a critical role 
during hemostasis and tissue repair as it promoted clot formation 
at the time of tissue injury while it dissolved the fibrin clot and 
promoted tissue regeneration during wound healing. CSE readily 
reduced the plasma recalcification time and thus it showed strong 
procoagulant activity and the procoagulant activity was abolished 
by both EDTA and EGTA. EDTA is a non specific divalent metal ion 
chelator while EGTA is specific for calcium ions. Therefore, it 
appears that the procoagulant activity was due to the 
metalloprotease/s which is most likely calcium ion dependent. 
Generally the metallo-proteases are predominantly the zinc ion 
dependent enzymes, however there are metalloprotease which are 
dependent on both calcium and zinc ions for their activity, for 
example, NN-PF3, the metalloprotease isolated from the Indian 
cobra (Naja naja) venom was known to contain both zinc and 
calcium ions and the activity was abolished by both EDTA and 
EGTA [24]. Normally the metal ions in metalloprotease are known 
to play both structural and catalytic role, and affecting any of the 
metal ion will affect the activity, thus CSE protease/s needs 
thorough investigation for its metal ion composition and biological 
activity. CSE did not alter the APTT while it reduced PT suggesting 
that it is affecting the extrinsic/tissue factor pathway of 
coagulation. Both EDTA and EGTA abolished the PT of CSE. 
Further, CSE readily caused the clotting of factor VII deficient 
plasma; therefore, it is highly likely that the CSE interfered in the 
plasma coagulation process and work in place of factor VII of the 
extrinsic pathway. This activity was also abolished by both EDTA 
and EGTA. In addition, CSE also hydrolyzed the fibrinogen and 
caused the formation of fibrin clot but at a very slower rate as clot 
formation seen only after 30 min of incubation and it was also 
abolished by EDTA and EGTA. Thus, during tissue damage, CSE 
appear to promote the clot formation through metalloprotease/s 
as both EDTA and EGTA abolished the plasma recalcification time, 
PT and coagulation of factor VII deficient plasma. Although not 
studied extensively, only few studies reported the procoagulant 
activity of plant products that are working through the extrinsic 
pathway of coagulation, for example, the methanolic leaf extract of 
Ageratum conyzoides and the cysteine protease from Ficus carica 
were found to show procoagulant activity through extrinsic 
pathway of coagulation [25-26]. However, the procoagulant 
activity has been reported in different extracts of plant latex, fruits 
like kiwi, pineapple and raspberries [27-28], while the activity has 
been extensively studied in animal venoms [29-31]. As the injury 
enter in to the healing phase, this will further trigger a complex 
event including clot dissolution, scavenging of the debris and 
tissue regeneration through controlled proliferation of cells 
including angiogenesis. Plasmin digests the fibrin net and the clot 
breaks down which will eventually be engulfed and removed by 
phagocytic system. This step appears crucial, as little alteration of 
this step would result in prominent scar and keloid formation. 
Further, excess accumulation of collagen and other connective 
tissue materials would lead to fibrosis and has been commonly 
seen in many surgical wounds. 
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Table 2: Estimation of antioxidant and free radical of granulation tissue 
Groups  Day 3  Day 7  Day 14  Day 21 
Superoxide dismutase (Units/mg) 
CSE treated  4.7±0.1***  5.7±0.2***  6.3±0.4*** 3.2±0.1*** 
Neosporin   4.8±0.2***  5.5±0.2***  6.0±0.3*** 3.4±0.3*** 
NC  2.9±0.4  4.5±0.3  5.0±0.4 5.5±0.1 
B-CSE treated  2.8±0.3  4.6±0.3  5.2±0.2 5.4±0.3 
Catalase (Units/mg) 
CSE treated 1.8±0.3** 2.4±0.4 3.0±0.4* 1.6±0.5*** 
Neosporin  1.9±0.3** 2.2±0.3 2.8±0.4 1.8±0.4** 
NC 0.7±0.2 1.6±0.3 2.1±0.4 2.9±0.4 
B-CSE treated 0.8±0.2 1.8±0.3 2.2±0.2 2.7±0.3 
Reduced glutathione (nano moles/mg) 
CSE treated 98±6*** 119±5 *** 173±4*** 202±4*** 
Neosporin  94±4*** 115±4*** 168±4*** 198±3*** 
NC 60±6 84±5 105±5 112±4 
B-CSE treated 62±5 86±5 106±3 121±4 
Scavenging of nitric oxide (Units/mg) 
CSE treated 0.56±0.03* 0.50±0.02* 0.15±0.02*** 0.062±0.01 
Neosporin  0.54±0.02* 0.50±0.01* 0.12±0.01*** 0.060±0.01* 
NC 0.60±0.03 0.57±0.02 0.52±0.03 0.110±0.03 
B-CSE treated 0.59±0.03 0.55±0.03 0.52±0.02 0.100±0.03 
Lipid peroxidation (nano moles/mg) 
CSE treated 32±6** 26±5 20±4 12±4* 
Neosporin  32±4 ** 25±4 20±3 12±3* 
NC 45±6 34±5 24±4 22±4 
B-CSE treated 42±5 32±5 25±3 22±4 
Myeloperoxidase (Units/mg) 
CSE treated 1.2±0.02*** 0.8±0.02*** 0.5±0.02*** 0.3±0.01*** 
Neosporin  1.3±0.02*** 0.9±0.01*** 0.5±0.01*** 0.4±0.01*** 
NC 1.9±0.02 1.3±0.02 0.9±0.02 0.8±0.01 
B-CSE treated 1.8±0.03 1.3±0.20 1.0±0.02 0.8±0.01  
Data are presented as the mean±SEM and analyzed using two-way ANOVA followed by Bonferroni post-tests (*** P<0.001, significant when 
compared to negative control group of mice). 
 
CSE hydrolyzed azocasein suggesting the plasminogen activation 
property and this was abolished by IAA and thus the role of Cysteine 
protease in the process. This is the first study reporting plasminogen 
activation by the cysteine protease; however cysteine proteases are 
abundantly present in lysosomes. Further, CSE readily hydrolyzed 
plasminogen free washed human fibrin clot suggesting the fibrinolytic 
or plasmin-like activity and the activity was abolished by PMSF, 
suggesting the role of serine protease. Several plants serine proteases 
degrade fibrin clot such as from Euphorbia hirta [32], Clausena 
suffruticosa, Leea indica and Leucas aspera [33]. Interestingly CSE 
inhibited platelet aggregation induced by collagen, ADP and 
epinephrine significantly and this activity was abolished by PMSF 
suggesting the role of serine proteases. Similarly the antiplatelet 
activity was reported from several fruits and vegetables, including 
black grapes (Vitis vinifera L.), pineapple (Ananas comosus L. Merr.), 
strawberry (Fragaria x ananassa L. Duch.), kiwi (Actinidia chinensis 
Planchon), vegetables such as garlic (Allium sativum L.), onion (Allium 
cepa L.), scallion (Allium schoenoprasum L.), tomato (Solanum 
lycopersicon Mill.), melon (Cucumis melo L. var. inodorus) and green 
beans [28]. Many serine proteases isolated from plants source such as 
bromelain from Ananas comosus [34] and Crinumin from Crinum 
asiaticum [35] showed the inhibition of platelet aggregation.  
Clot formation and clot dissolution properties are the crucial steps 
during wound healing and the wound contraction is the process of 
mobilizing healthy skin surrounding the wound to cover the 
denuded(without epidermis) area and this involves complex and 
orchestrate interaction of cells, extracellular matrix, and cytokines. 
Since CSE enhanced wound contraction, it would either have 
enhanced contractile property of myofibroblasts or increased the 
number of myofibroblasts through controlled prolifereation. An 
increased hydroxyproline, hexosamine and hexuronic acid content 
of granulation tissue reflects the increased rate of wound healing. In 
addition, the histology of granulation tissue sections of CSE and 
Neosporin treated mice showed abundance of collagen tissue and 
neovascularisation with few inflammatory cells on 14th day of 
treatment compared to NC and B-CSE which suggests augmented the 
wound healing process. During wound healing ROS and as well as 
non radical oxidants play vital role in healing and serve as cellular 
messengers that drive numerous biological pathways. For example, 
at optimum micro molar concentration, hydrogen peroxide can 
promote vascular endothelial growth factor (VEGF) expression in 
keratinocytes [36]. It has been reported earlier that topical 
application of compounds with free radical scavenging properties in 
patients has shown to improve wound healing significantly and 
protect tissues from oxidative damage [37]. Over production of ROS 
results in oxidative stress, thereby causing cytotoxicity and delayed 
wound healing. Therefore, elimination of ROS could be an important 
strategy in healing of chronic wounds [38]. The initial increased 
SOD, CAT, GSH levels and their decreased pattern after 14th day and 
the decreased levels of NO, LPO and MPO at 21st day in CSE treated 
granulation tissue suggests the significant antioxidant activity. 
Reduction of free radicals and MPO levels could prevent oxidative 
damage and promote the healing processes. Thus, cucumber sap is a 
depot of a spectrum of proteases which readily interfere in 
hemostasis. Hemostasis is an acute phase response to vascular 
injury and involves platelet activation, clot formation and clot 
dissolution. Metalloproteases (factor VIIa like) promote blood 
coagulation that is required to stop bleeding while cysteine 
(plasminogen activation) and serine (fibrinolytic and antiplatelet) 
proteases are found to play essential role in clot dissolution and 
platelet aggregation inhibition during wound healing.  
CONCLUSION 
In conclusion this systematic study not only uncover the beneficial 
properties of the proteases of cucumber sap but also provide the 
scientific basis for the wide use of cucumber in cosmetic industry 
and as well as in traditional medicine as a skin conditioner and 
cleansing agent during wound healing and in the treatment of 
conditions such as acne and other skin disorders.  
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